CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sanofi India Ltd (Parent) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sanofi India Ltd (Parent)
54/A
Sir Mathuradas Vasanji Road
Phone: +91 2228032000p:+91 2228032000 MUMBAI, 400072  India Fax: +91 2228032846f:+91 2228032846

Business Summary
Sanofi India Limited is a healthcare company. The Company is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals. It offers a range of medicines and supplements for treatment of diabetes (both insulin and orals), cardiology, thrombosis, epilepsy, allergies, and infections. It has two manufacturing sites, one in Hyderabad and one in Goa. Its geographical segments include India, Singapore, and Others. It sells its products through independent distributors primarily in India. It also manufactures its products through third party manufacturers. The different types of dosage forms include tablets, capsules (hard and soft), eye/ear drops, ampoules, vials, creams, and ointment. Its brands include Lantus, Allegra, and Combiflam. Its vaccine products include Adacel, Avaxim 80U/160U, FluQuadri, Hexaxim, Menactra, Tetraxim, Vaxigrip, Stamaril, Shanvac-B and ShanTT. Its consumer healthcare products include Allegra, Allegra nasal, and Avil.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/202012/31/2013Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Independent Chairman of the Board AdityaDitya 6/2/2016 4/29/2016
Chief Financial Officer, Whole-Time Director VaibhavKarandikar 49 11/1/2021 10/6/2020
Compliance Officer, Company Secretary RadhikaShah 1/1/2022 11/1/2021
11 additional Officers and Directors records available in full report.

Business Names
Business Name
Aventis Pharma Limited (Parent)
Sanofi India Limited

General Information
Number of Employees: 2,943 (As of 12/31/2011)
Outstanding Shares: 23,030,622 (As of 12/31/2020)
Shareholders: 13,862
Fax Number: +91 2228032846


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, September 26, 2023